Comparative brain tissue distribution of camptothecin and topotecan in the rat

Cancer Chemotherapy and Pharmacology

Volumn 43, Issue 5, 1999, Pages 364-370

  El Gizawy, Sanaa A ^a   Hedaya, Mohsen A ^b  

^a TANTA UNIVERSITY   (Egypt)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Brain distribution; Camptothecin; Microdialysis; Pharmacokinetics; Topotecan

Indexed keywords

CAMPTOTHECIN; TOPOTECAN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM TUMOR; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG UPTAKE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN; CAMPTOTHECIN; EXTRACELLULAR SPACE; INJECTIONS, INTRAVENOUS; MALE; MICRODIALYSIS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; TOPOTECAN;

EID: 0033032877     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050908     Document Type: Article

References (29)

1. Baker SD, Heideman RL, Crom WR, Kuttesch JF, Gajjar A, Stewart CF (1996) Cerebrospinal fluid pharmacokinetics and penetration of continuos infusion topotecan in children with central nervous system tumors. Cancer Chemother Pharmacol 37: 195
2. Benveniste H, Diemer NH (1987) Cellular reaction to implantation of a microdialysis tube in the rat hippocampus. Acta Neuropathol 74: 234
3. Blaney SM, Cole DE, Balis FM, Godwin K, Poplack DG (1993) Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. Cancer Res 53: 725
4. Blaney SM, Cole DE, Godwin K, Sung C, Poplack DG, Balis FM (1995) Intrathecal administration of topotecan in nonhuman primates. Cancer Chemother Pharmacol 36: 121
5. Blasberg R, Patlak CS, Fenstermacher JD (1975) Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. J Pharmacol Exp Ther 195: 73
6. Burke TG, Munshi CB, Mi Z, Jiang Y (1995) The important role of albumin in determining the relative human blood stability of the camptothecin anticancer drugs. J Pharm Sci 84: 518
7. Davson H, Segal MB (1996) Physiology of the CSF and blood-brain barriers. CRC Press, Boca Raton, p 1
8. Fassberg J, Stella VJ (1992) A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J Pharm Sci 81: 676
9. Friedman HS, Houghton PJ. (1996) Treatment of central nervous system xenografts with camptothecins. Ann N Y Acad Sci 803: 210
10. Friedman HS, Houghton PJ, Schold C, Keir S, Bigner DD (1994) Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts. Cancer Chemother Pharmacol 34: 171
11. Gibaldi M, Perrier D (1982) Estimation of areas. In: Swarbrick J (ed) Pharmacokinetics, 2nd edn. Marcel Dekker, New York, p 445
12. Gottlieb JA, Guarino AM, Call JB, Oliverio VT, Block JB (1970) Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880). Cancer Chemother Rep 54: 461
13. Hare CB, Elion CB, Houghton PJ, Houghton JA, Keir S, Marcelli SL, Bigner DD, Friedman HS (1997) Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[piperidino]-1-piperidino)-carbonyloxy-campothecin against pediatric and adult central nervous system tumor xenografts. Cancer Chemother Pharmacol 39: 187
14. Hertzberg RP, Caranfa MJ, Holden KG, Jakas DR, Gallegher G, Mattern MR, Mong SM, Bartus JO, Johnson RK, Kingsbury WD (1989) Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity. J Med Chem 32: 715
15. Hsiang YH, Liu LF (1988) Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 48: 1722
16. Hsiang YH, Hertzberg R, Hecht S, Liu LF (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260: 14873
17. Kessel DH, Bossman HB, Lohr K (1972) Camptothecin effects on DNA synthesis in murine leukemia cells. Biochem Biophys Acta 269: 210
18. Liu LF (1989) DNA topoisomerase poisons as antitumor drugs Annu Rev Biochem 58: 351
19. Malhotra BK, Lemaire M, Sawchuk RJ (1994) Investigation of the distribution of EAB 515 to cortical ECF and CSF in freely moving rats utilizing microdialysis. Pharm Res 11: 1223
20. Menacherry S, Hubert W, Justice JB (1992) In vivo calibration of microdialysis probes for exogenous compounds. Anal Chem 64: 577
21. Mi Z, Burke TG (1994) Differential interactions of camptothecin lactone and carboxylate forms with human blood components. Biochemistry 33: 10325
22. Munshi CB, Mi Z, Burke TG (1995) The biophysics underlying the favorable stability of the topotecan anticancer drug in human blood (abstract). Proc Am Assoc Cancer Res 36: 444
23. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. 2nd edn. Academic Press, San Diego, Plates 10 and 11
24. Scott DO, Bindra DS, Stella VJ (1993) Plasma pharmacokinetics of the lactone and carboxylate forms of 20(s)-camptothecin in anesthetized rats. Pharm Res 10: 1451
25. Sung C, Blaney SM, Cole DE, Balis FM, Dedrick RL (1994) A pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluid. Cancer Res 54: 5118
26. Wall ME, Wani MC (1977) Antineoplastic agents from plants. Annu Rev Pharmacol Toxicol 17: 117
27. Wall ME, Wani MC, Cook CE, Plamer KH, McPhail AT, Sim GA (1966) Plant antitumor agents. 1. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Campotheca acuminata. J Am Chem Soc 88: 3888
28. Wang JC (1985) DNA topoisomerases. Annu Rev Biochem 45: 665
29. Wani MC, Ronman PE, Lindley JT, Wall ME (1980) Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogs. J Med Chem 23: 554